AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS01186	EGF-like domain signature 2.	120	131	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS00022	EGF-like domain signature 1.	120	131	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Pfam	PF00008	EGF-like domain	61	92	1.2E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Pfam	PF00008	EGF-like domain	98	129	8.3E-7	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSiteProfiles	PS50026	EGF-like domain profile.	21	57	16.415	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SUPERFAMILY	SSF57196		58	95	4.99E-7	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	CDD	cd00054	EGF_CA	62	94	0.00860113	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SUPERFAMILY	SSF57196		22	59	1.42E-8	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSiteProfiles	PS50026	EGF-like domain profile.	58	91	8.18	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SUPERFAMILY	SSF57196		142	173	6.12E-5	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSiteProfiles	PS50026	EGF-like domain profile.	94	132	18.411	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS01186	EGF-like domain signature 2.	160	171	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Gene3D	G3DSA:2.10.25.10		139	175	4.7E-5	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SMART	SM00181		97	132	5.1E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SMART	SM00181		24	57	0.0038	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SMART	SM00181		60	94	2.2E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SMART	SM00181		140	172	2.3	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Gene3D	G3DSA:2.10.25.10		97	136	5.1E-10	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS00022	EGF-like domain signature 1.	160	171	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	SUPERFAMILY	SSF57196		97	135	1.81E-10	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Pfam	PF12661	Human growth factor-like EGF	144	166	0.0035	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Pfam	PF12661	Human growth factor-like EGF	30	51	0.042	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS01186	EGF-like domain signature 2.	45	56	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSitePatterns	PS00022	EGF-like domain signature 1.	45	56	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Gene3D	G3DSA:2.10.25.10		59	96	1.1E-8	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	Gene3D	G3DSA:2.10.25.10		14	58	7.5E-10	T	27-11-2017
AGZ84279.1	f541ca4323ac0523c1e45b850baed3bd	176	ProSiteProfiles	PS50026	EGF-like domain profile.	137	172	12.494	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	188	199	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	110	121	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		87	122	0.058	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		12	46	8.2E-5	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		49	84	2.6E-5	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		243	277	1.9E-5	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		166	200	2.9E-6	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		203	238	1.3E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		125	161	1.4E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00181		282	313	16.0	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	188	199	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF00008	EGF-like domain	244	275	1.5E-4	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF00008	EGF-like domain	13	43	2.8E-5	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF00008	EGF-like domain	167	198	3.0E-6	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF00008	EGF-like domain	50	81	9.1E-8	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		240	283	1.51E-6	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		5	47	2.0E-10	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		123	154	1.3E-9	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		250	279	7.8E-11	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		96	122	2.4E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		6	46	1.83E-7	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		240	277	0.028	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		204	238	0.35	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		279	313	0.35	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		50	84	0.57	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		9	46	0.33	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		163	200	0.016	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SMART	SM00179		122	161	0.063	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	72	83	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	240	277	15.791	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	226	237	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	163	200	20.447	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF12661	Human growth factor-like EGF	131	155	0.015	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Pfam	PF12661	Human growth factor-like EGF	93	116	0.063	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	279	313	8.741	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	1	7	6.581	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		280	319	8.7E-4	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		123	167	5.08E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	301	312	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		165	201	2.87E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	149	160	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		203	240	4.42E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.60.120.200		78	95	0.12	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.60.120.200		194	211	0.31	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.60.120.200		155	174	0.011	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.60.120.200		234	249	0.0032	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	149	160	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		212	233	3.1E-10	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		49	85	6.84E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	265	276	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	46	84	19.133	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	9	43	13.704	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		48	77	2.8E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	226	237	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	72	83	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	201	238	13.252	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS01186	EGF-like domain signature 2.	301	312	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		86	123	6.62E-8	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	265	276	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	Gene3D	G3DSA:2.10.25.10		175	193	5.3E-12	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	SUPERFAMILY	SSF57196		280	318	4.2E-5	T	27-11-2017
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSitePatterns	PS00022	EGF-like domain signature 1.	34	45	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	122	161	17.784	T	27-11-2017	IPR000742	EGF-like domain		
AGZ84282.1	9dadb339084eae6bf05617db93099832	322	ProSiteProfiles	PS50026	EGF-like domain profile.	85	119	8.911	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		216	241	6.7E-10	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		150	175	1.1E-10	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		85	109	5.8E-11	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF57196		439	478	1.26E-7	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF53300		513	710	6.82E-40	T	27-11-2017	IPR036465	von Willebrand factor A-like domain superfamily		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	CDD	cd00054	EGF_CA	358	387	1.28348E-5	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF57184		125	257	8.89E-10	T	27-11-2017	IPR009030	Growth factor receptor cysteine-rich domain superfamily		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF57184		275	403	1.41E-11	T	27-11-2017	IPR009030	Growth factor receptor cysteine-rich domain superfamily		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF00092	von Willebrand factor type A domain	529	696	5.2E-27	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF57196		400	439	2.72E-5	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	277	314	7.924	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:3.40.50.410		528	716	1.4E-27	T	27-11-2017	IPR036465	von Willebrand factor A-like domain superfamily		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	164	175	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		320	339	3.2E-6	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		440	459	1.5E-10	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	399	438	7.044	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	CDD	cd00054	EGF_CA	439	467	4.05397E-4	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		217	256	7.7E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		442	478	4.0E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		323	357	1.4E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		85	124	1.7E-6	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		361	398	5.1E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		402	438	0.0032	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		21	58	2.7	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		482	519	1.9	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		151	190	5.3E-6	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00181		280	319	6.1E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	230	241	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	439	473	11.29	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		242	275	2.9E-9	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		176	215	4.4E-10	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		301	319	7.7E-8	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		110	149	2.1E-10	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		340	357	2.1E-8	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		64	84	6.2E-5	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		460	482	5.8E-9	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	358	393	11.402	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	452	463	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS01187	Calcium-binding EGF-like domain signature.	439	461	-	T	27-11-2017	IPR018097	EGF-like calcium-binding, conserved site	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		276	300	1.3E-9	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		358	378	1.9E-9	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS01187	Calcium-binding EGF-like domain signature.	358	381	-	T	27-11-2017	IPR018097	EGF-like calcium-binding, conserved site	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		379	398	3.7E-6	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	214	251	7.171	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	CDD	cd01450	vWFA_subfamily_ECM	528	685	1.15681E-29	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	82	124	9.499	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50234	VWFA domain profile.	529	703	23.32	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.40.490.10		417	439	1.3E-8	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		483	527	1.9E-5	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS01187	Calcium-binding EGF-like domain signature.	277	302	-	T	27-11-2017	IPR018097	EGF-like calcium-binding, conserved site	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	98	109	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	333	344	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	148	190	8.949	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		358	398	2.8E-11	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		82	124	3.6E-11	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		277	319	4.6E-10	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		439	478	1.2E-11	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		399	438	0.67	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		321	357	3.2E-4	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		214	256	4.3E-10	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00179		148	190	8.4E-11	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		399	416	1.4E-4	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SUPERFAMILY	SSF57196		76	117	8.38E-8	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS01186	EGF-like domain signature 2.	342	356	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Gene3D	G3DSA:2.10.25.10		22	58	0.0044	T	27-11-2017
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	372	383	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSiteProfiles	PS50026	EGF-like domain profile.	320	357	10.228	T	27-11-2017	IPR000742	EGF-like domain		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	214	255	2.4E-8	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	82	123	5.9E-8	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	439	477	8.4E-8	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	277	318	8.2E-8	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	148	189	5.5E-8	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	Pfam	PF07645	Calcium-binding EGF domain	358	397	5.4E-7	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	293	304	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68008.1	2bf283e57078a064b8b57ecc172b065f	716	SMART	SM00327		527	700	6.1E-26	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	MobiDBLite	mobidb-lite	consensus disorder prediction	1004	1037	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		100	120	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		414	474	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		616	716	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	MobiDBLite	mobidb-lite	consensus disorder prediction	125	203	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		240	300	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		938	960	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	MobiDBLite	mobidb-lite	consensus disorder prediction	500	578	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		476	496	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		724	812	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		970	990	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		12	34	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		38	98	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		366	410	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	Coils	Coil		320	362	-	T	27-11-2017
ACV41934.1	f6aad6a73f2a444dca4957f4e7fb6272	1153	MobiDBLite	mobidb-lite	consensus disorder prediction	820	905	-	T	27-11-2017
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	SUPERFAMILY	SSF57256		19	73	4.84E-8	T	27-11-2017	IPR036645	Elafin-like superfamily		
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	Gene3D	G3DSA:4.10.75.10		23	76	3.7E-11	T	27-11-2017	IPR036645	Elafin-like superfamily		
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	SMART	SM00217		25	74	3.2E-4	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	SUPERFAMILY	SSF57283		97	117	7.59E-6	T	27-11-2017	IPR036201	Pacifastin domain superfamily	GO:0030414	Reactome: R-HSA-5083635|Reactome: R-HSA-5173214
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	PRINTS	PR00003	4-disulphide core signature	65	73	9.6E-7	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	PRINTS	PR00003	4-disulphide core signature	22	31	9.6E-7	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	PRINTS	PR00003	4-disulphide core signature	46	53	9.6E-7	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	PRINTS	PR00003	4-disulphide core signature	53	62	9.6E-7	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	Pfam	PF00095	WAP-type (Whey Acidic Protein) 'four-disulfide core'	25	73	4.4E-8	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	Gene3D	G3DSA:2.10.70.10		80	114	7.7E-9	T	27-11-2017
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	ProSiteProfiles	PS51390	WAP-type 'four-disulfide core' domain profile.	22	74	14.879	T	27-11-2017	IPR008197	WAP-type 'four-disulfide core' domain	GO:0005576|GO:0030414	
AGZ84283.1	25c03be9bf421597d00c02d8e0cbd7cd	122	Pfam	PF05375	Pacifastin inhibitor (LCMII)	97	118	1.9E-8	T	27-11-2017	IPR008037	Pacifastin domain	GO:0030414	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:2.10.25.10		102	132	2.8E-9	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	CDD	cd01450	vWFA_subfamily_ECM	208	368	1.56714E-38	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSiteProfiles	PS50234	VWFA domain profile.	209	383	26.138	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SUPERFAMILY	SSF53300		204	389	8.9E-45	T	27-11-2017	IPR036465	von Willebrand factor A-like domain superfamily		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	CDD	cd00054	EGF_CA	159	189	8.7496E-10	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	173	184	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:3.40.50.410		207	390	4.5E-36	T	27-11-2017	IPR036465	von Willebrand factor A-like domain superfamily		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:2.10.25.10		32	76	2.4E-4	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSiteProfiles	PS50026	EGF-like domain profile.	159	199	11.818	T	27-11-2017	IPR000742	EGF-like domain		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Pfam	PF00092	von Willebrand factor type A domain	209	380	7.3E-35	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Pfam	PF07645	Calcium-binding EGF domain	97	127	1.4E-6	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Pfam	PF07645	Calcium-binding EGF domain	159	198	9.6E-9	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00179		159	199	8.2E-11	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00179		40	75	0.27	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00179		97	137	7.3E-9	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSitePatterns	PS01187	Calcium-binding EGF-like domain signature.	159	182	-	T	27-11-2017	IPR018097	EGF-like calcium-binding, conserved site	GO:0005509	
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:2.10.25.10		133	162	9.2E-6	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	PRINTS	PR00453	Von Willebrand factor type A domain signature	247	261	4.3E-5	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	PRINTS	PR00453	Von Willebrand factor type A domain signature	314	322	4.3E-5	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	PRINTS	PR00453	Von Willebrand factor type A domain signature	208	225	4.3E-5	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00327		207	388	8.9E-35	T	27-11-2017	IPR002035	von Willebrand factor, type A		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:2.10.25.10		163	206	4.6E-15	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSitePatterns	PS00010	Aspartic acid and asparagine hydroxylation site.	111	122	-	T	27-11-2017	IPR000152	EGF-type aspartate/asparagine hydroxylation site		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	CDD	cd00054	EGF_CA	97	127	1.33184E-7	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00181		162	199	1.1E-4	T	27-11-2017	IPR000742	EGF-like domain		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00181		39	75	6.5	T	27-11-2017	IPR000742	EGF-like domain		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SMART	SM00181		100	137	0.025	T	27-11-2017	IPR000742	EGF-like domain		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	ProSiteProfiles	PS50026	EGF-like domain profile.	97	132	9.002	T	27-11-2017	IPR000742	EGF-like domain		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	Gene3D	G3DSA:2.10.25.10		77	101	3.9E-5	T	27-11-2017
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SUPERFAMILY	SSF57184		40	143	1.19E-6	T	27-11-2017	IPR009030	Growth factor receptor cysteine-rich domain superfamily		
ABR68007.1	0df1cf56b431c646504ab98e29de53bb	390	SUPERFAMILY	SSF57196		159	193	8.38E-9	T	27-11-2017
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Pfam	PF01607	Chitin binding Peritrophin-A domain	138	184	9.5E-10	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Pfam	PF01607	Chitin binding Peritrophin-A domain	57	101	9.5E-7	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Pfam	PF01607	Chitin binding Peritrophin-A domain	360	405	5.1E-6	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SUPERFAMILY	SSF57625		355	405	9.68E-9	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SUPERFAMILY	SSF57625		131	194	4.71E-12	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	ProSiteProfiles	PS50940	Chitin-binding type-2 domain profile.	357	406	8.623	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Gene3D	G3DSA:2.170.140.10		352	406	1.2E-8	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Gene3D	G3DSA:2.170.140.10		123	196	5.3E-14	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	Gene3D	G3DSA:2.170.140.10		48	122	9.8E-9	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SMART	SM00494		132	186	1.1E-11	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SMART	SM00494		55	109	7.4E-8	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SMART	SM00494		358	405	2.0	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	SUPERFAMILY	SSF57625		54	108	2.62E-10	T	27-11-2017	IPR036508	Chitin binding domain superfamily	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	MobiDBLite	mobidb-lite	consensus disorder prediction	180	342	-	T	27-11-2017
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	ProSiteProfiles	PS50940	Chitin-binding type-2 domain profile.	131	186	11.693	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ACI41238.1	45019cf92c34e6f7e689917a03afad10	406	ProSiteProfiles	PS50940	Chitin-binding type-2 domain profile.	54	109	10.716	T	27-11-2017	IPR002557	Chitin binding domain	GO:0005576|GO:0006030|GO:0008061	Reactome: R-HSA-189085
ADI48487.1	ed5b3ca62a6d7d54091258923c6a4af2	1019	MobiDBLite	mobidb-lite	consensus disorder prediction	989	1019	-	T	27-11-2017
ADI48487.1	ed5b3ca62a6d7d54091258923c6a4af2	1019	MobiDBLite	mobidb-lite	consensus disorder prediction	1	832	-	T	27-11-2017
ADI48487.1	ed5b3ca62a6d7d54091258923c6a4af2	1019	MobiDBLite	mobidb-lite	consensus disorder prediction	934	968	-	T	27-11-2017
ADI48487.1	ed5b3ca62a6d7d54091258923c6a4af2	1019	MobiDBLite	mobidb-lite	consensus disorder prediction	867	916	-	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF57567		802	861	1.96E-6	T	27-11-2017	IPR036084	Serine protease inhibitor-like superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50228	SUEL-type lectin domain profile.	3657	3744	11.18	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF49785		2400	2554	1.86E-29	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS51406	Fibrinogen C-terminal domain profile.	19	72	11.732	T	27-11-2017	IPR002181	Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50022	Coagulation factors 5/8 type C domain (FA58C) profile.	1412	1567	22.019	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF49785		1743	1898	4.11E-35	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00216		2590	2752	2.9E-23	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00216		3237	3400	1.5E-28	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00216		513	676	1.6E-21	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF12714	TILa domain	860	914	3.5E-10	T	27-11-2017	IPR025615	TILa domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF12714	TILa domain	2922	2977	1.7E-6	T	27-11-2017	IPR025615	TILa domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF12714	TILa domain	3580	3631	1.5E-6	T	27-11-2017	IPR025615	TILa domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.60.120.260		2397	2554	2.6E-28	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.60.120.260		1093	1250	3.7E-29	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF49785		1096	1247	3.47E-30	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50026	EGF-like domain profile.	479	517	14.763	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:3.90.215.10		19	139	6.4E-7	T	27-11-2017	IPR014716	Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00057	FA58C	1743	1898	8.22912E-36	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF57567		2862	2923	8.18E-8	T	27-11-2017	IPR036084	Serine protease inhibitor-like superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		474	520	1.1E-4	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF49785		2067	2218	1.13E-41	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS01186	EGF-like domain signature 2.	2976	2990	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS00022	EGF-like domain signature 1.	2582	2593	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Coils	Coil		3278	3298	-	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF49785		1416	1566	1.86E-27	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF12248	Farnesoic acid 0-methyl transferase	275	370	1.6E-16	T	27-11-2017	IPR022041	Farnesoic acid O-methyl transferase		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00057	FA58C	2404	2553	9.71041E-27	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50228	SUEL-type lectin domain profile.	3001	3089	9.289	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00231		2399	2554	2.6E-9	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00231		1413	1567	0.11	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00231		2066	2217	7.6E-16	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00231		1092	1248	0.031	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00231		1740	1899	1.3E-13	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF02140	Galactose binding lectin domain	3767	3848	9.8E-7	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF02140	Galactose binding lectin domain	3011	3088	1.4E-5	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF02140	Galactose binding lectin domain	394	469	1.3E-17	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF02140	Galactose binding lectin domain	3119	3198	7.8E-14	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF02140	Galactose binding lectin domain	3665	3743	9.0E-14	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00094	von Willebrand factor type D domain	2600	2752	1.4E-29	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00094	von Willebrand factor type D domain	523	677	2.3E-18	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00094	von Willebrand factor type D domain	3251	3400	3.5E-30	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50022	Coagulation factors 5/8 type C domain (FA58C) profile.	1092	1248	29.72	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.60.120.260		1412	1569	5.7E-22	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.60.120.260		1739	1899	3.0E-32	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.60.120.260		2064	2219	5.9E-41	T	27-11-2017	IPR008979	Galactose-binding-like domain superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00179		3208	3245	0.02	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00179		2556	2594	0.22	T	27-11-2017	IPR001881	EGF-like calcium-binding domain	GO:0005509	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00054	EGF_CA	2556	2594	0.00104003	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		2949	2995	1.4E-5	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50228	SUEL-type lectin domain profile.	3105	3199	11.5	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50026	EGF-like domain profile.	2556	2594	19.584	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS01285	Coagulation factors 5/8 type C domain (FA58C) signature 1.	2439	2468	-	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		3205	3247	3.3E-9	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50228	SUEL-type lectin domain profile.	384	470	12.177	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50026	EGF-like domain profile.	2951	2991	9.75	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS51233	VWFD domain profile.	522	731	32.771	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		2555	2601	2.5E-9	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS51233	VWFD domain profile.	3250	3468	37.156	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50022	Coagulation factors 5/8 type C domain (FA58C) profile.	2399	2554	27.699	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00754	F5/8 type C domain	1109	1245	7.5E-17	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00754	F5/8 type C domain	1757	1895	6.0E-20	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00754	F5/8 type C domain	2083	2214	6.5E-21	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00754	F5/8 type C domain	2419	2550	7.9E-12	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00754	F5/8 type C domain	1451	1560	1.4E-12	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Coils	Coil		3852	3853	-	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF56496		20	72	3.14E-5	T	27-11-2017	IPR036056	Fibrinogen-like, C-terminal		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS51233	VWFD domain profile.	2599	2812	39.613	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS00022	EGF-like domain signature 1.	3233	3244	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF57567		3525	3575	1.47E-5	T	27-11-2017	IPR036084	Serine protease inhibitor-like superfamily		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50022	Coagulation factors 5/8 type C domain (FA58C) profile.	2067	2217	35.891	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		2866	2916	100.0	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		2954	2991	10.0	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		3610	3647	180.0	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		892	928	100.0	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		2559	2594	2.3E-4	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		482	517	0.042	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00181		3211	3245	1.5E-4	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS00022	EGF-like domain signature 1.	505	516	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF08742	C8 domain	3452	3517	6.1E-16	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF08742	C8 domain	722	802	1.9E-5	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF08742	C8 domain	2796	2863	4.1E-15	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF01826	Trypsin Inhibitor like cysteine rich domain	806	859	1.8E-7	T	27-11-2017	IPR002919	Trypsin Inhibitor-like, cysteine rich domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF01826	Trypsin Inhibitor like cysteine rich domain	2867	2921	5.0E-8	T	27-11-2017	IPR002919	Trypsin Inhibitor-like, cysteine rich domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00832		3445	3518	2.0E-16	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SMART	SM00832		2789	2864	1.3E-17	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF57196		3209	3246	3.64E-7	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00057	FA58C	2071	2216	1.43334E-37	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00057	FA58C	1097	1247	4.12356E-25	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Pfam	PF00008	EGF-like domain	3212	3242	7.8E-5	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50022	Coagulation factors 5/8 type C domain (FA58C) profile.	1739	1899	30.075	T	27-11-2017	IPR000421	Coagulation factor 5/8 C-terminal domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00054	EGF_CA	3210	3245	0.00577663	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSitePatterns	PS01186	EGF-like domain signature 2.	3233	3244	-	T	27-11-2017	IPR013032	EGF-like, conserved site		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50228	SUEL-type lectin domain profile.	3759	3849	9.163	T	27-11-2017	IPR000922	D-galactoside/L-rhamnose binding SUEL lectin domain	GO:0030246	
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		801	874	2.3E-11	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		3517	3592	3.6E-10	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	Gene3D	G3DSA:2.10.25.10		2862	2936	1.1E-15	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	ProSiteProfiles	PS50026	EGF-like domain profile.	3208	3245	16.654	T	27-11-2017	IPR000742	EGF-like domain		
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	SUPERFAMILY	SSF57196		2557	2603	3.53E-7	T	27-11-2017
AHN92641.1	9d6ff359c7d656bdeeb7ba8ce91b0a0b	3853	CDD	cd00057	FA58C	1415	1566	2.62874E-23	T	27-11-2017
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	ProDom	PD968187	BETA-DEFENSIN ANTIBIOTIC PRECURSOR ANTIMICROBIAL DEFENSIN BETA SIGNAL DEFENSIN BD-32 DEFB-32	559	650	3.0E-4	T	27-11-2017
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	MobiDBLite	mobidb-lite	consensus disorder prediction	397	636	-	T	27-11-2017
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	MobiDBLite	mobidb-lite	consensus disorder prediction	660	751	-	T	27-11-2017
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	PRINTS	PR01216	Adhesive plaque protein signature	2	18	1.3E-47	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	PRINTS	PR01216	Adhesive plaque protein signature	105	124	1.3E-47	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	PRINTS	PR01216	Adhesive plaque protein signature	40	61	1.3E-47	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	PRINTS	PR01216	Adhesive plaque protein signature	82	99	1.3E-47	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
BAA09851.1	512d023c3e95cccdc33bf64ba10fc19e	751	MobiDBLite	mobidb-lite	consensus disorder prediction	158	359	-	T	27-11-2017
ADI48489.1	377e8f879fae20d595099b24cdbca00b	571	MobiDBLite	mobidb-lite	consensus disorder prediction	239	294	-	T	27-11-2017
ADI48489.1	377e8f879fae20d595099b24cdbca00b	571	MobiDBLite	mobidb-lite	consensus disorder prediction	386	425	-	T	27-11-2017
ADI48489.1	377e8f879fae20d595099b24cdbca00b	571	MobiDBLite	mobidb-lite	consensus disorder prediction	188	219	-	T	27-11-2017
GH160603.1_translated	48c6e3358b404d8e189e36c460e1c0ad	153	SUPERFAMILY	SSF63887		32	69	9.55E-5	T	27-11-2017	IPR009033	Calreticulin/calnexin, P domain superfamily	GO:0005509|GO:0005515	
AFP57565.1	1a8044f88829ea722dc3e420d16005b5	1223	MobiDBLite	mobidb-lite	consensus disorder prediction	174	963	-	T	27-11-2017
AFP57565.1	1a8044f88829ea722dc3e420d16005b5	1223	MobiDBLite	mobidb-lite	consensus disorder prediction	31	75	-	T	27-11-2017
AFP57565.1	1a8044f88829ea722dc3e420d16005b5	1223	MobiDBLite	mobidb-lite	consensus disorder prediction	985	1196	-	T	27-11-2017
AFP57565.1	1a8044f88829ea722dc3e420d16005b5	1223	MobiDBLite	mobidb-lite	consensus disorder prediction	97	143	-	T	27-11-2017
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	MobiDBLite	mobidb-lite	consensus disorder prediction	734	781	-	T	27-11-2017
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	Pfam	PF12042	Tubuliform egg casing silk strands structural domain	127	261	1.7E-5	T	27-11-2017	IPR021915	Tubuliform egg casing silk strands structural domain		
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	MobiDBLite	mobidb-lite	consensus disorder prediction	1	20	-	T	27-11-2017
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	MobiDBLite	mobidb-lite	consensus disorder prediction	44	82	-	T	27-11-2017
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	MobiDBLite	mobidb-lite	consensus disorder prediction	263	307	-	T	27-11-2017
ADK92884.1	173be5710050ae176f6ee0e5bcd6c9f0	1012	MobiDBLite	mobidb-lite	consensus disorder prediction	494	541	-	T	27-11-2017
ADI48488.1	fb6a456f060e44fe6b7b9ed56b561f7f	508	MobiDBLite	mobidb-lite	consensus disorder prediction	192	223	-	T	27-11-2017
ADI48488.1	fb6a456f060e44fe6b7b9ed56b561f7f	508	MobiDBLite	mobidb-lite	consensus disorder prediction	103	147	-	T	27-11-2017
ADI48488.1	fb6a456f060e44fe6b7b9ed56b561f7f	508	MobiDBLite	mobidb-lite	consensus disorder prediction	237	338	-	T	27-11-2017
AAY46226.1	73d52665ccb6172f706d8006c7cd817c	561	Gene3D	G3DSA:2.160.20.50		454	513	2.8E-4	T	27-11-2017	IPR016133	Insect cysteine-rich antifreeze protein		
AAY46226.1	73d52665ccb6172f706d8006c7cd817c	561	Pfam	PF01391	Collagen triple helix repeat (20 copies)	459	510	1.3E-8	T	27-11-2017	IPR008160	Collagen triple helix repeat		
AAY46226.1	73d52665ccb6172f706d8006c7cd817c	561	MobiDBLite	mobidb-lite	consensus disorder prediction	452	507	-	T	27-11-2017
AAF89278.1	da03a1a9df9756d7df51367a2993f375	72	Pfam	PF04202	Foot protein 3	1	71	8.1E-45	T	27-11-2017	IPR007328	Foot protein 3		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	Pfam	PF00094	von Willebrand factor type D domain	364	469	6.1E-8	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	Pfam	PF00094	von Willebrand factor type D domain	34	172	1.1E-9	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	SUPERFAMILY	SSF57567		267	324	2.13E-7	T	27-11-2017	IPR036084	Serine protease inhibitor-like superfamily		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	SUPERFAMILY	SSF57603		318	364	3.66E-5	T	27-11-2017
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	Gene3D	G3DSA:2.10.70.10		331	357	2.1E-6	T	27-11-2017
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	Gene3D	G3DSA:2.10.25.10		263	330	4.0E-11	T	27-11-2017
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	Pfam	PF08742	C8 domain	210	263	1.4E-5	T	27-11-2017	IPR014853	Uncharacterised domain, cysteine-rich		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	ProSiteProfiles	PS51233	VWFD domain profile.	33	236	14.679	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AAK15299.1	7e19ee45f86eea4102c3b09ce46a98ba	472	ProSiteProfiles	PS51233	VWFD domain profile.	362	472	13.061	T	27-11-2017	IPR001846	von Willebrand factor, type D domain		
AAY29119.1	013b1d031150fbafafde87eb442dc637	157	MobiDBLite	mobidb-lite	consensus disorder prediction	24	105	-	T	27-11-2017
ACI41239.1	1f609b2d874a5a8cb08e6414f404b02a	714	SUPERFAMILY	SSF141571		534	652	6.93E-5	T	27-11-2017
ACI41239.1	1f609b2d874a5a8cb08e6414f404b02a	714	MobiDBLite	mobidb-lite	consensus disorder prediction	394	457	-	T	27-11-2017
ACI41239.1	1f609b2d874a5a8cb08e6414f404b02a	714	MobiDBLite	mobidb-lite	consensus disorder prediction	92	126	-	T	27-11-2017
ACI41239.1	1f609b2d874a5a8cb08e6414f404b02a	714	Gene3D	G3DSA:2.160.20.80		497	665	1.9E-10	T	27-11-2017
ACI41239.1	1f609b2d874a5a8cb08e6414f404b02a	714	MobiDBLite	mobidb-lite	consensus disorder prediction	52	79	-	T	27-11-2017
AAZ94729.1	0bfa7d709cd3683ee4501b5abc65a3a3	69	Pfam	PF04202	Foot protein 3	1	64	1.7E-15	T	27-11-2017	IPR007328	Foot protein 3		
CCD57502.1	b5d979a056bfebb4e3ec6b4651096f2d	212	MobiDBLite	mobidb-lite	consensus disorder prediction	133	212	-	T	27-11-2017
CCD57502.1	b5d979a056bfebb4e3ec6b4651096f2d	212	MobiDBLite	mobidb-lite	consensus disorder prediction	22	121	-	T	27-11-2017
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	ProDom	PD968187	BETA-DEFENSIN ANTIBIOTIC PRECURSOR ANTIMICROBIAL DEFENSIN BETA SIGNAL DEFENSIN BD-32 DEFB-32	318	434	3.0E-4	T	27-11-2017
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	MobiDBLite	mobidb-lite	consensus disorder prediction	467	555	-	T	27-11-2017
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	PRINTS	PR01216	Adhesive plaque protein signature	40	61	4.1E-45	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	PRINTS	PR01216	Adhesive plaque protein signature	123	142	4.1E-45	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	PRINTS	PR01216	Adhesive plaque protein signature	100	117	4.1E-45	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
AAX23968.1	eb37aad57cf5cc7c373d8e837ffbf2c3	565	PRINTS	PR01216	Adhesive plaque protein signature	2	18	4.1E-45	T	27-11-2017	IPR002964	Adhesive plaque protein	GO:0005576	
AAK98794.1	be437818dbf0102f113b6be063a2917c	334	SUPERFAMILY	SSF101967		119	218	5.62E-5	T	27-11-2017
CCD57460.1	9b606b83e6ae8d4bf92ac440bbd619f0	237	ProSiteProfiles	PS51257	Prokaryotic membrane lipoprotein lipid attachment site profile.	1	15	5.0	T	27-11-2017
CCD57480.1	93c893e0284f39cfb3f397737561d22c	236	MobiDBLite	mobidb-lite	consensus disorder prediction	23	236	-	T	27-11-2017
AFP57562.1	c714f3c5190037b0d99e1e71f9841cfc	422	Gene3D	G3DSA:1.20.120.20		250	419	1.0E-5	T	27-11-2017
BAE94409.1	515fccc888b2fa4a0950814e60736b73	198	MobiDBLite	mobidb-lite	consensus disorder prediction	45	68	-	T	27-11-2017
AAY29122.1	b6dfa872f76c7b710de5f9943d754ef2	343	MobiDBLite	mobidb-lite	consensus disorder prediction	29	343	-	T	27-11-2017
AAY29116.1	1bd41bd5bd4831480bfb5310704a7a06	205	ProSiteProfiles	PS51257	Prokaryotic membrane lipoprotein lipid attachment site profile.	1	16	5.0	T	27-11-2017
AAY29116.1	1bd41bd5bd4831480bfb5310704a7a06	205	Gene3D	G3DSA:3.90.1150.10		36	93	0.24	T	27-11-2017	IPR015422	Pyridoxal phosphate-dependent transferase, subdomain 2	GO:0003824	
CCD57439.1	8898edb976f12a9dd92e5b8ee8ce0733	234	ProSiteProfiles	PS51257	Prokaryotic membrane lipoprotein lipid attachment site profile.	1	16	5.0	T	27-11-2017
AAF75279.1	bdca48e09260585b251d13068df07322	430	MobiDBLite	mobidb-lite	consensus disorder prediction	219	430	-	T	27-11-2017
AAY29115.1	66cd65dac09a0ef47a54652032827176	190	ProSiteProfiles	PS51257	Prokaryotic membrane lipoprotein lipid attachment site profile.	1	16	5.0	T	27-11-2017
ABE01084.1	1bf9a90ae26e1a57efc1765c5d61456a	96	ProSiteProfiles	PS51257	Prokaryotic membrane lipoprotein lipid attachment site profile.	1	18	5.0	T	27-11-2017
